- Home
- GERN vs EQBK Comparison
GERN vs EQBK Comparison
Compare GERN & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- EQBK
- Stock Information
- Founded
- GERN 1990
- EQBK 2002
- Country
- GERN United States
- EQBK United States
- Employees
- GERN N/A
- EQBK N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- EQBK Major Banks
- Sector
- GERN Health Care
- EQBK Finance
- Exchange
- GERN Nasdaq
- EQBK Nasdaq
- Market Cap
- GERN 823.0M
- EQBK 806.8M
- IPO Year
- GERN 1996
- EQBK 2015
- Fundamental
- Price
- GERN $1.24
- EQBK $41.67
- Analyst Decision
- GERN Buy
- EQBK Buy
- Analyst Count
- GERN 7
- EQBK 6
- Target Price
- GERN $3.17
- EQBK $47.80
- AVG Volume (30 Days)
- GERN 7.6M
- EQBK 101.2K
- Earning Date
- GERN 11-06-2025
- EQBK 10-14-2025
- Dividend Yield
- GERN N/A
- EQBK 1.72%
- EPS Growth
- GERN N/A
- EQBK N/A
- EPS
- GERN N/A
- EQBK 1.00
- Revenue
- GERN $164,447,000.00
- EQBK $186,307,000.00
- Revenue This Year
- GERN $172.62
- EQBK $13.14
- Revenue Next Year
- GERN $56.87
- EQBK $39.83
- P/E Ratio
- GERN N/A
- EQBK $41.72
- Revenue Growth
- GERN 11877.20
- EQBK 18.09
- 52 Week Low
- GERN $1.09
- EQBK $34.11
- 52 Week High
- GERN $4.50
- EQBK $50.85
- Technical
- Relative Strength Index (RSI)
- GERN 43.70
- EQBK 54.52
- Support Level
- GERN $1.19
- EQBK $40.15
- Resistance Level
- GERN $1.31
- EQBK $41.43
- Average True Range (ATR)
- GERN 0.07
- EQBK 1.34
- MACD
- GERN -0.01
- EQBK 0.04
- Stochastic Oscillator
- GERN 17.31
- EQBK 77.08
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.